Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 176,560 |
|
|||||
| News | - | ||||||
| Day High | 0.625 | Low High |
|||||
| Day Low | 0.5501 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ensysce Biosciences Inc | ENSC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0375 | 6.86% | 0.5842 | 18:49:28 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.59 | 0.5501 | 0.625 | 0.5842 | 0.5467 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 437 | 176,560 | US$ 0.5931919 | US$ 104,734 | - | 0.53 - 7.20 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:05:15 | 1 | US$ 0.6102 | USD |
Ensysce Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42.19M | 3.15M | - | 2.23M | -10.63M | -3.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ensysce Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/15/2024 | 11:19 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/14/2024 | 16:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 05:05 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/23/2024 | 14:45 | AllPennyStocks.com | Biotech Soars On FDA Announcement |
| 1/16/2024 | 20:56 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 12/29/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/19/2023 | 15:27 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 12/19/2023 | 15:24 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/30/2023 | 13:37 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
| 11/29/2023 | 08:24 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/21/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 11/17/2023 | 16:19 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENSC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6075 | 0.625 | 0.53 | 0.5602903 | 77,488 | -0.0233 | -3.84% |
| 1 Month | 0.78 | 0.8668 | 0.53 | 0.7049719 | 96,956 | -0.1958 | -25.10% |
| 3 Months | 1.42 | 1.56 | 0.53 | 0.9401336 | 228,140 | -0.8358 | -58.86% |
| 6 Months | 1.07 | 2.06 | 0.53 | 1.34 | 837,329 | -0.4858 | -45.40% |
| 1 Year | 3.68 | 7.20 | 0.53 | 2.00 | 625,848 | -3.10 | -84.13% |
| 3 Years | 3,825.60 | 4,108.80 | 0.53 | 507.70 | 1,711,287 | -3,825.02 | -99.98% |
| 5 Years | 3,825.60 | 4,108.80 | 0.53 | 507.70 | 1,711,287 | -3,825.02 | -99.98% |
Ensysce Biosciences Description
| Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. |
